Freecash introduces a zero-investment way to earn money by watching movies 
Taxinexo Advances Large-Scale Commercial Deployment of Level 4 Autonomous Vehicles Across the United States 
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering 
Authority Engine Launches AI Ads Engine, Delivering 37% Click-Through Rates and $0.06 Cost Per Action Through Autonomous Campaign Optimization Spark Power Builds Momentum Throughout Quarter; Optimistic About Second Half Performance
Second Quarter revenue grows 41.1% Year over Year to $65.4 million Renewables segment continues strong…
Neos Networks transforms Perth & Kinross Council’s infrastructure with the completion of its DCMS-funded Local Full Fibre Network project
Delivery achieved significantly ahead of schedule, despite the need to navigate challenges such as the…
Oxurion NV – Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science, the American Academy of Ophthalmology Journal
THR-687 is a potent pan-RGD integrin antagonist holding potential as next generation first line therapy…
Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil
Nasally administered Foralumab, once a day for 10 consecutive days, was well-tolerated and produced significant…
Basilea reports strong financial results for half-year 2021 with significantly increased cash flow from marketed brands and increases 2021 full-year guidance
CHF 46.1 million (+26% year-on-year) non-deferred Cresemba and Zevtera revenue, including CHF 23.6 million royalty…
Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland
ORION CORPORATION PRESS RELEASE 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022
Continued strength in unit demand across key product lines Rupall unit demand growth of 44%…
Chalice Brands Ltd. To Present at the Q3 Virtual Investor Summit
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings…
Celularity Reports Second Quarter 2021 Financial Results
Secured funding of approximately $138 million through merger and private placement investment in public equity…
Zogenix Reports Granting of Inducement Awards
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation…
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
Corvus Partner Angel Pharmaceuticals Plans to Initiate Trial by Year-end 2021 BURLINGAME, Calif., Aug. 16,…
Lowell Farms Inc. Announces Record Revenues and Record Cultivation Output for the Second Quarter
Lowell Reports 37% sequential growth in revenue driven by large cultivation yields advances and strong…
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0,…
Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative…
Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials…
Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results
Announced first patient dosed in Phase 1 trial evaluating KIN-2787 in patients with BRAF mutation-positive solid…